Duffy Sean P. sold 12,944 shares of Omada Health, Inc. at $19.22 for −$249k on Nov 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Executive Officer
Chief Executive Officer
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$248,730.61Shares × reported price
Shares traded
12,944Common Stock
Price per share
$19.22Reported price. Read footnotes for ranges.
% of reported position traded
3.27%This security and ownership context
Holdings after
382,594Direct
Trade date
Nov 4, 2026Sell
Filed
Nov 6, 2026, 4:38 PM ET2-day reporting delay
Accession
0001610717-26-000446Code S · Transaction 394973
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 395,538 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Option exercise12,944$5.82$75,334.08Trade 394972
Nov 4, 2026Option exercise12,944$0.00$0Trade 394974
3 transaction rows in this filing. Joint filers share the same rows.

OMDA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
OMDA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +11%1w ago +1.2%1d ago −2%
Returns since7d −24%30d90d180d1y

Footnotes in full

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the Reporting Person. F2: This transaction was executed in multiple trades at prices ranging from $19.11 to $19.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein. F4: 100% of the shares subject to the option are fully vested and exercisable.